About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Gper1tm1.1Lmlf
targeted mutation 1.1, L M Leeb-Lundberg
MGI:3837567
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Gper1tm1.1Lmlf/Gper1tm1.1Lmlf B6.129-Gper1tm1.1Lmlf MGI:3837658


Genotype
MGI:3837658
hm1
Allelic
Composition
Gper1tm1.1Lmlf/Gper1tm1.1Lmlf
Genetic
Background
B6.129-Gper1tm1.1Lmlf
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gper1tm1.1Lmlf mutation (0 available); any Gper1 mutation (30 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• female mice exhibit slightly reduced glucagons release in response to low (18%) and high-glucose (12%) compared to in wild-type mice
• however, male mice exhibit normal glucagons secretion in response to glucose stimulation
• PGE2-treated islet cells fail to exhibit decreased glucagons in response to glucose stimulation unlike wild-type cells
• in response to low and high glucose levels, female mice exhibit a 35% and 57%, respectively, decrease in insulin release compared to similarly treated wild-type mice
• however, the fold stimulation by glucose, tolbutamide and high potassium ion is normal
• ovariectomized female mice failed to exhibit an increase in pancreatic insulin content unlike similarly treated wild-type mice
• treatment of ovariectomized female mice with PGE2 fail to increase pancreatic insulin content unlike in similarly treated wild-type mice
• PGE2-treated islet cells fails to increases insulin release in response to glucose stimulation unlike in similarly treated wild-type cells
• 13% in female mice at 6 months of age
• female mice exhibit depressed glucagons levels 10 minutes after glucose challenge compared to wild-type mice
• in female mice, but not in male mice, at 6 months of age
• female mice exhibit diminished first-phase insulin response to glucose challenge compared to similarly treated wild-type mice
• however, male mice exhibit normal glucose tolerance
• normal insulin and glucagon response to PGE2 is abolished

endocrine/exocrine glands
• female mice exhibit slightly reduced glucagons release in response to low (18%) and high-glucose (12%) compared to in wild-type mice
• however, male mice exhibit normal glucagons secretion in response to glucose stimulation
• PGE2-treated islet cells fail to exhibit decreased glucagons in response to glucose stimulation unlike wild-type cells
• in response to low and high glucose levels, female mice exhibit a 35% and 57%, respectively, decrease in insulin release compared to similarly treated wild-type mice
• however, the fold stimulation by glucose, tolbutamide and high potassium ion is normal
• ovariectomized female mice failed to exhibit an increase in pancreatic insulin content unlike similarly treated wild-type mice
• treatment of ovariectomized female mice with PGE2 fail to increase pancreatic insulin content unlike in similarly treated wild-type mice
• PGE2-treated islet cells fails to increases insulin release in response to glucose stimulation unlike in similarly treated wild-type cells

growth/size/body
• in female mice only
• in female mice only

cardiovascular system
• at 9 months, the lumen circumference of resistance arteries is reduced 23% and media to lumen ratio is increased 45% compared to in wild-type mice
• however, mice exhibit normal thoracic arteries dimensions and media thickness
• at 9 months, female mice exhibit a 23% elevation in mean arterial blood pressure compared to in wild-type mice

limbs/digits/tail
• in female mice only

skeleton
• in female mice only





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory